Clinical Trial Update: Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6 Inhibitors in Breast Cancer Patients (TDHOME) [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating capillary microsampling for therapeutic drug monitoring of CDK4/6 inhibitors in breast cancer patients, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ibrance (palbociclib) (palbociclib)
• Kisqali (ribociclib) (ribociclib)
• Verzenio (abemaciclib) (abemaciclib)

Snippet

Sponsor: Institut Curie | Conditions: Breast Cancer | NA | Status: NOT_YET_RECRUITING